Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry
Not available === text
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/11297 |
| id |
ndltd-UTEXAS-oai-repositories.lib.utexas.edu-2152-11297 |
|---|---|
| record_format |
oai_dc |
| spelling |
ndltd-UTEXAS-oai-repositories.lib.utexas.edu-2152-112972015-09-20T16:59:26ZStock market valuation and firm-level determinants of innovative activity in the pharmaceutical industrySkrepnek, Grant HaroldPharmaceutical industry--Technological innovationsTechnological innovations--Economic aspectsNot availabletext2011-05-23T21:42:24Z2011-05-23T21:42:24Z2002-082011-05-23electronichttp://hdl.handle.net/2152/11297engCopyright is held by the author. Presentation of this material on the Libraries' web site by University Libraries, The University of Texas at Austin was made possible under a limited license grant from the author who has retained all copyrights in the works.Restricted |
| collection |
NDLTD |
| language |
English |
| format |
Others
|
| sources |
NDLTD |
| topic |
Pharmaceutical industry--Technological innovations Technological innovations--Economic aspects |
| spellingShingle |
Pharmaceutical industry--Technological innovations Technological innovations--Economic aspects Skrepnek, Grant Harold Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| description |
Not available === text |
| author |
Skrepnek, Grant Harold |
| author_facet |
Skrepnek, Grant Harold |
| author_sort |
Skrepnek, Grant Harold |
| title |
Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| title_short |
Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| title_full |
Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| title_fullStr |
Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| title_full_unstemmed |
Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| title_sort |
stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry |
| publishDate |
2011 |
| url |
http://hdl.handle.net/2152/11297 |
| work_keys_str_mv |
AT skrepnekgrantharold stockmarketvaluationandfirmleveldeterminantsofinnovativeactivityinthepharmaceuticalindustry |
| _version_ |
1716821433467797504 |